New Jersey A1789 classifies sterile syringe access programs as inherently beneficial uses.

New Jersey A1789 amends the Municipal Land Use Law to classify sterile syringe access programs as inherently beneficial uses. This designation aims to facilitate the establishment of such programs, which are designed to prevent the spread of HIV, hepatitis C, and other bloodborne pathogens. By recognizing these programs as inherently beneficial, the bill seeks to make it easier for municipalities to approve and support their operation, thereby increasing access to these critical health services.

New Jersey A1789 classifies sterile syringe access programs as inherently beneficial uses.

New Jersey A1789 amends the Municipal Land Use Law to classify sterile syringe access programs as inherently beneficial uses. This designation aims to facilitate the establishment of such programs, which are designed to prevent the spread of HIV, hepatitis C, and other bloodborne pathogens. By recognizing these programs as inherently beneficial, the bill seeks to make it easier for municipalities to approve and support their operation, thereby increasing access to these critical health services.